" /> Molybdenum cofactor deficiency, type b - CISMeF





Preferred Label : Molybdenum cofactor deficiency, type b;

Symbol : MOCODB;

CISMeF acronym : MOCODB;

Type : Phenotype, molecular basis known;

Alternative titles and symbols : Molybdenum cofactor deficiency, complementation group b;

Description : Molybdenum cofactor deficiency is a rare autosomal recessive metabolic disorder characterized by neonatal onset of intractable seizures, opisthotonus, and facial dysmorphism associated with hypouricemia and elevated urinary sulfite levels. Affected individuals show severe neurologic damage and often die in early childhood (summary by Reiss et al., 1999). For a general phenotypic description and a discussion of genetic heterogeneity of MOCOD, see MOCODA (252150), which is clinically indistinguishable from MOCODB.;

Inheritance : Autosomal recessive;

Molecular basis : Caused by mutation in the molybdenum cofactor synthesis gene 2 (MOCS2, 603708.0001);

Laboratory abnormalities : Decreased xanthine dehydrogenase activity; Decreased sulfite oxidase activity; Hypouricemia; Molybdenum cofactor deficiency; Increased urinary hypoxanthine; Increased urinary taurine; Increased urinary S-sulfocysteine; Xanthine stones; Increased urinary xanthine;

Prefixed ID : #252160;

Details


You can consult :


Nous contacter.
03/05/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.